Editorial

Dear Readers and Authors,

I am pleased to bring you volume 8, issue 2 of Pharmacognosy Com- munications. In this issue we present new research reports examining the pharmacognosy of several important medicinal plants including the anticancer activity of Fagaropsis angolensis and the antiviral activity of Dicrocephala integrifolia against herpes simplex type-1 virus. We also present a study which examines both the anti-giardial and anticancer properties of extracts prepared from Terminalia ferdinandiana kinos. Two antibacterial studies are also presented: one examining the growth inhibitory properties of Glycyrrhiza glabra and the other examining Withania somnifera. Both studies screened the respective extracts against a panel of bacteria known to induce autoimmune inflammatory diseases in genetically susceptible individuals, so may have further implications beyond antibacterial activity. Furthermore, both studies also report the ability of these extracts to potentiate the activity of conventional antibiotics in antibiotic resistant strains.